AFG210 is a novel first-generation “type II” FLT3 inhibitor. References: Weisberg E, Roesel J, Furet P, Bold G, Imbach P, FlA?rsheimer A, Caravatti G, Jiang J, Manley P, Ray A, Griffin JD. Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison. Genes Cancer. 2010 Oct;1(10):1021-32. doi: 10.1177/1947601910396505. PubMed PMID: 21779428; PubMed Central PMCID: PMC3092267.

纯度：≥98%

CAS：228400-22-4